In conjunction with the 7th CCBIO Symposium Omid Farokzhad will deliver a Volterra lecture Tuesday May 14th titled "Perspectives on how to Translate Biomedical Research to Products and Cures" The lecture is held at Solstrand Hotel&Bad near Bergen and is open for everyone.
In cooperation with CCBIO - Centre for Cancer Biomarkers, VIS Innovation and the University of Bergen Faculty of Medicine.
Tuesday May 14th, 1530 -1630
Location: Solstrand Hotel&Bad, Os
Omid Farokhzad is a Professor at Harvard Medical School (HMS) and a physician-scientist in the Department of Anesthesiology at Brigham and Women’s Hospital (BWH). Dr. Farokhzad established and directs the Center for Nanomedicine at BWH. He is a faculty member of the Brigham Research Institute Cancer Research Center and the Dana Farber/Harvard Cancer Center. Dr. Farokhzad and his team of scientists have developed a myriad of nanotechnologies for medical applications. The technologies that Dr. Farokhzad and colleagues have developed formed the basis for the launch of 5 biotechnology companies: BIND Therapeutics, Selecta Biosciences , Tarveda Therapeutics , Placon Therapeutics , Seer Biosciences These companies are translating the aforementioned academic innovations toward commercialization and societal impact. Dr. Farokhzad completed his post-graduate clinical and post-doctoral research trainings, respectively, at the BWH/HMS and MIT in the laboratory of Institute Professor Robert Langer. He received his M.D. and M.A. from Boston University School of Medicine and his M.B.A. from the MIT Sloan School of Management.
The Centre for Digital Life has chosen to honour the Italian mathematical biologist Vito Volterra with a continuous lecture series with high profile contributors within the field of digital biotechnology and life sciences.
Vito Volterra became professor of rational mathematics at the University of Pisa in the late 1800s, where he developed his theory of functionals, leading to contributions within integral and integro-differential equations.